Balance Ophthalmics, Inc.
Ophthalmic therapeutic treatments for progressive vision loss diseases
- Sector
- Medtech
- Headquarters
- SIOUX FALLS, SD
- Founded
- 2023
- Latest Form D
- $3.7M, Oct 2024
- Total capital
- $5.7M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $5.7M
- 2 Form D · last Oct 2024
- 25 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 4
- 7 pending · first 2024
- Rank in peer group#4 of 29
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 2nd filing$3.7M
- Private capital raisedForm D · SEC · 1st filing$2M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 29 peers
Line = medianMedtech · Molecule
- Granted patents#4 · top 14%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- John BerdahlResearcherExecutive Officer, DirectorLinked by 4 patents
- Alison BauerleinDirectorNamed in SEC Form D filings
- Matt LarsonDirectorNamed in SEC Form D filings
- Philip PhillipsDirectorNamed in SEC Form D filings
- Seph JensenExecutive Officer, DirectorNamed in SEC Form D filings
- Stuart RaetzmanDirectorNamed in SEC Form D filings
What it has protected
USPTO · 4 granted of 11- PendingEye Treatment Apparatus And Method With Independent Pressure SourcesUSPTOApplication 19536864
- GrantedEye Treatment Apparatus And Method With Independent Pressure SourcesUSPTOUS 12,575,999
- PendingTherapeutic Eye Treatment With GasesUSPTOApplication 19302159
Show all 11 patent records
- Eye Treatment Apparatus And Method With Independent Pressure SourcesJun 25, 2026 · Application 19536864Pending
- Eye Treatment Apparatus And Method With Independent Pressure SourcesMar 17, 2026 · US 12,575,999Granted
- Therapeutic Eye Treatment With GasesDec 11, 2025 · Application 19302159Pending
- Therapeutic Eye Treatment With GasesSep 16, 2025 · US 12,414,898Granted
- Apparatus And Methods To Adjust Ocular Blood FlowJul 31, 2025 · Application 19075150Pending
- Apparatus And Methods To Adjust Ocular Blood FlowApr 22, 2025 · US 12,279,825Granted
- Eye Treatment Apparatus And Method With Independent Pressure SourcesJul 16, 2024 · US 12,036,180Granted
- Ocular Health Index Determination And UsageJun 20, 2024 · Application 18287275Pending
- Eye-related Intrabody Pressure Identification And ModificationApr 18, 2024 · Application 18538603Pending
- Apparatus And Methods To Treat HeadachesJul 22, 2021 · Application 17225539Pending
- Eye-related Intrabody Pressure Identification And ModificationMar 11, 2021 · Application 17077205Pending
Related companies, and why
- Lodestone Biomedical, Inc.Similar federal contract value in Medtech · null in contracts
- ReGelTec, Inc.Similar federal contract value in Medtech · null in contracts
- Rhinomed Health CorpSimilar federal contract value in Medtech · null in contracts
- Perimeter Medical Imaging AI, Inc.Similar federal contract value in Medtech · null in contracts
- Profound Medical Corp.Similar federal contract value in Medtech · null in contracts
- Free Flow Medical, Inc.Similar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .